International Biotechnology (LON:IBT) Insider Katherine Cornish-Bowden Purchases 1,500 Shares

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden bought 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average cost of GBX 713 ($8.96) per share, for a total transaction of £10,695 ($13,446.06).

International Biotechnology Stock Performance

LON IBT opened at GBX 708 ($8.90) on Thursday. The company has a fifty day moving average of GBX 695.19 and a two-hundred day moving average of GBX 678.39. The company has a market capitalization of £261.68 million, a PE ratio of 1,475.00 and a beta of 0.21. International Biotechnology has a 1 year low of GBX 588 ($7.39) and a 1 year high of GBX 734 ($9.23). The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32.

International Biotechnology Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, January 24th. Investors of record on Thursday, December 19th will be given a GBX 15.56 ($0.20) dividend. The ex-dividend date of this dividend is Thursday, December 19th. This is a boost from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. International Biotechnology’s dividend payout ratio is 6,041.67%.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.